Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 4/2016

01-11-2016 | Erratum

Erratum to: Use of signals and systems engineering to improve the safety of warfarin initiation

Authors: G. Hyun, J. Li, A. R. Bass, A. Mohapatra, S. C. Woller, H. Lin, C. Eby, G. A. McMillin, B. F. Gage

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2016

Login to get access

Excerpt

The original version of Appendix 2 unfortunately contained a typo in Eq. 3. The corrected equation for \(\ln \left( {\text{dose estimate}} \right) = \ln \left({\text{therapeutic dose}} \right) \cdot [1-0.088({\text{therapeutic INR}} - {\text{Target INR)]}}.\) …
Metadata
Title
Erratum to: Use of signals and systems engineering to improve the safety of warfarin initiation
Authors
G. Hyun
J. Li
A. R. Bass
A. Mohapatra
S. C. Woller
H. Lin
C. Eby
G. A. McMillin
B. F. Gage
Publication date
01-11-2016
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2016
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1412-x

Other articles of this Issue 4/2016

Journal of Thrombosis and Thrombolysis 4/2016 Go to the issue

OriginalPaper

Patient satisfaction with extended-interval warfarin monitoring

OriginalPaper

Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study)

OriginalPaper

Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation

OriginalPaper

Persistent neutrophilia is a marker for an increased risk of venous thrombosis

OriginalPaper

Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients

OriginalPaper

Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits